Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention.
CONCLUSIONS: Considering the UK healthcare system perspective, percutaneous PFO closure in cryptogenic ischemic stroke patients is a cost-effective stroke prevention strategy compared to medical therapy alone. Its cost-effectiveness was driven by substantial reduction in recurrent strokes and patients' improved health-related quality-of-life.
PMID: 29564942 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Clinical Trials | Economics | Health Management | Ischemic Stroke | Patent Foramen Ovale | Stroke | Study | UK Health